Walking the Patient Path

Date & Time:

Originally aired Friday, 8 May, 2020

Friday, 8 May
11 a.m. EDT (NA) / 4 p.m. BST (UK) / 5 p.m. CEST (EU-Central)
(60 min)


Today, both clinical trial challenges and regulatory pressure are driving the need for patient centricity. These include:

  • Increase in protocol complexity
  • Failure to meet recruitment targets
  • Trials needing to be extended
  • Decreasing number of eligible patients

In this complimentary webinar, experts from PPD and Evidera will discuss capturing the patient voice and applying it to the successful design and execution of your study.

Now, more than ever, it’s critical to understand that patient experience encompasses far more than the endpoints and outcomes that are typically measured by clinical trials. Patients want to know whether a treatment — or a trial — will improve their quality of life and not impose an undue burden on their daily routine. In fact, the patient perspective is now recognized as an integral part of designing and executing studies that deliver real-world value for patients.

Register and learn how having a holistic patient lens optimizes strategic product development. The session will conclude with an open question and answer discussion.


Join this free webinar where a patient provides perspectives on clinical research and experts from PPD will guide you through strategies to:

  • Incorporate the patient voice to optimize study design and conduct
  • Increase patient access to clinical trials
  • Reduce patient burden
  • Improve the patient experience in a clinical trial


Sara Ashenfelter

Sara Ashenfelter
Patient and PPD Employee

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 24,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.